Breaking News
May 3, 2019 - Vaping and Smoking May Signal Greater Motivation to Quit
May 3, 2019 - Dementia looks different in brains of Hispanics
May 3, 2019 - Short-Staffed Nursing Homes See Drop In Medicare Ratings
May 3, 2019 - Study of teens with eating disorders explores how substance users differ from non-substance users
May 3, 2019 - Scientists develop new video game that may help in the study of Alzheimer’s
May 3, 2019 - Arc Bio introduces Galileo Pathogen Solution product line at ASM Clinical Virology Symposium
May 3, 2019 - Cornell University study uncovers relationship between starch digestion gene and gut bacteria
May 3, 2019 - How to Safely Use Glucose Meters and Test Strips for Diabetes
May 3, 2019 - Anti-inflammatory drugs ineffective for prevention of Alzheimer’s disease
May 3, 2019 - Study tracks Pennsylvania’s oil and gas waste-disposal practices
May 3, 2019 - Creating a better radiation diagnostic test for astronauts
May 3, 2019 - Vegans are often deficient in these four nutrients
May 3, 2019 - PPDC announces seed grants to develop medical devices for children
May 3, 2019 - Study maps out the frequency and impact of water polo head injuries
May 3, 2019 - Research on Reddit identifies risks associated with unproven treatments for opioid addiction
May 3, 2019 - Good smells may help ease tobacco cravings
May 3, 2019 - Medical financial hardship found to be very common among people in the United States
May 3, 2019 - Researchers develop multimodal system for personalized post-stroke rehabilitation
May 3, 2019 - Study shows significant mortality benefit with CABG over percutaneous coronary intervention
May 3, 2019 - Will gene-editing of human embryos ever be justifiable?
May 3, 2019 - FDA Approves Dengvaxia (dengue vaccine) for the Prevention of Dengue Disease in Endemic Regions
May 3, 2019 - Why Tonsillitis Keeps Coming Back
May 3, 2019 - Fighting the opioid epidemic with data
May 3, 2019 - Maggot sausages may soon be a reality
May 3, 2019 - Deletion of ATDC gene prevents development of pancreatic cancer in mice
May 2, 2019 - Targeted Therapy Promising for Rare Hematologic Cancer
May 2, 2019 - Alzheimer’s disease is a ‘double-prion disorder,’ study shows
May 2, 2019 - Reservoir bugs: How one bacterial menace makes its home in the human stomach
May 2, 2019 - Clinical, Admin Staff From Cardiology Get Sneak Peek at Epic
May 2, 2019 - Depression increases hospital use and mortality in children
May 2, 2019 - Vicon and NOC support CURE International to create first gait lab in Ethiopia
May 2, 2019 - Researchers use 3D printer to make paper organs
May 2, 2019 - Viral infection in utero associated with behavioral abnormalities in offspring
May 2, 2019 - U.S. Teen Opioid Deaths Soaring
May 2, 2019 - Opioid distribution data should be public
May 2, 2019 - In the Spotlight: “I’m learning every single day”
May 2, 2019 - 2019 Schaefer Scholars Announced
May 2, 2019 - Podcast: KHN’s ‘What The Health?’ Bye-Bye, ACA, And Hello ‘Medicare-For-All’?
May 2, 2019 - Study describes new viral molecular evasion mechanism used by cytomegalovirus
May 2, 2019 - SLU study suggests a more equitable way for Medicare reimbursement
May 2, 2019 - Scientists discover first gene involved in lower urinary tract obstruction
May 2, 2019 - Researchers identify 34 genes associated with increased risk of ovarian cancer
May 2, 2019 - Many low-income infants receive formula in the first few days of life, finds study
May 2, 2019 - Global study finds high success rate for hip and knee replacements
May 2, 2019 - Taking depression seriously: What is it?
May 2, 2019 - With Head Injuries Mounting, Will Cities Put Their Feet Down On E-Scooters?
May 2, 2019 - Scientists develop small fluorophores for tracking metabolites in living cells
May 2, 2019 - Study casts new light into how mothers’ and babies’ genes influence birth weight
May 2, 2019 - Researchers uncover new brain mechanisms regulating body weight
May 2, 2019 - Organ-on-chip systems offered to Asia-Pacific regions by Sydney’s AXT
May 2, 2019 - Adoption of new rules drops readmission penalties against safety net hospitals
May 2, 2019 - Kids and teens who consume zero-calorie sweetened beverages do not save calories
May 2, 2019 - Improved procedure for cancer-related erectile dysfunction
May 2, 2019 - Hormone may improve social behavior in autism
May 2, 2019 - Alzheimer’s disease may be caused by infectious proteins called prions
May 2, 2019 - Even Doctors Can’t Navigate Our ‘Broken Health Care System’
May 2, 2019 - Study looks at the impact on criminal persistence of head injuries
May 2, 2019 - Honey ‘as high in sugars as table sugar’
May 2, 2019 - Innovations to U.S. food system could help consumers in choosing healthy foods
May 2, 2019 - FDA Approves Mavyret (glecaprevir and pibrentasvir) as First Treatment for All Genotypes of Hepatitis C in Pediatric Patients
May 2, 2019 - Women underreport prevalence and intensity of their own snoring
May 2, 2019 - Concussion summit focuses on science behind brain injury
May 2, 2019 - Booker’s Argument For Environmental Justice Stays Within The Lines
May 2, 2019 - Cornell research explains increased metastatic cancer risk in diabetics
May 2, 2019 - Mount Sinai study provides fresh insights into cellular pathways that cause cancer
May 2, 2019 - Researchers to study link between prenatal pesticide exposures and childhood ADHD
May 2, 2019 - CoGEN Congress 2019: Speakers’ overviews
May 2, 2019 - A new strategy for managing diabetic macular edema in people with good vision
May 2, 2019 - Sagent Pharmaceuticals Issues Voluntary Nationwide Recall of Ketorolac Tromethamine Injection, USP, 60mg/2mL (30mg per mL) Due to Lack of Sterility Assurance
May 2, 2019 - Screen time associated with behavioral problems in preschoolers
May 2, 2019 - Hormone reduces social impairment in kids with autism | News Center
May 2, 2019 - Researchers synthesize peroxidase-mimicking nanozyme with low cost and superior catalytic activity
May 2, 2019 - Study results of a potential drug to treat Type 2 diabetes in children announced
May 2, 2019 - Multigene test helps doctors to make effective treatment decisions for breast cancer patients
May 2, 2019 - UNC School of Medicine initiative providing unique care to dementia patients
May 2, 2019 - Nestlé Health Science and VHP join forces to launch innovative COPES program for cancer patients
May 2, 2019 - Study examines how our brain generates consciousness and loses it during anesthesia
May 2, 2019 - Transition Support Program May Aid Young Adults With Type 1 Diabetes
May 2, 2019 - Study shows how neutrophils exacerbate atherosclerosis by inducing smooth muscle-cell death
May 2, 2019 - Research reveals complexity of how we make decisions
Brown researchers awarded $12 million NIH grant renewal to explore fundamentals of brain function

Brown researchers awarded $12 million NIH grant renewal to explore fundamentals of brain function

Brown University’s Center for Central Nervous System Function, part of the Carney Institute for Brain Science, has been awarded a $12 million grant renewal from the National Institutes of Health’s Centers of Biomedical Research Excellence (COBRE) program. The funding will support the research center for the next five years.

With a focus on the genetic and neural basis for attention, decision-making and action, the expansion of research in the Center for Central Nervous System Function will complement Brown’s broader scientific discovery at the Carney Institute in the areas of cognitive neuroscience, computational neuroscience, neurobiology of brain circuits and brain imaging, recording and stimulation.

“Our goal is to develop fundamental knowledge about higher-order nervous system function,” said Jerome Sanes, a Brown professor of neuroscience who leads the center. “With this support, we will work on understanding fundamental properties in the brain from decision-making to sensory perception. The five new projects funded through this grant are models of a wide range of neural processes — from making decisions to detecting objects in the world around you to going through sequential tasks in your daily life.”

COBRE is a National Institute for General Medical Sciences program that aims to bolster research and mentorship of promising junior faculty members. Researchers at eligible institutions can apply for up to three five-year phases of COBRE support. Brown’s central nervous system program is in its second phase, with an $11 million award in 2013 launching the center.

The new $12 million federal grant follows on the heels of a $100 million gift to the Carney Institute to advance work on how the brain functions as well as finding cures for some of the world’s most devastating diseases, from ALS to Alzheimer’s.

Sanes said that phase one COBRE funding focused on developing institutional research infrastructure and helping junior investigators establish research projects so they could successfully compete for other grants. The junior researchers from phase one published almost 60 papers and received approximately $20 million in additional funding from the National Institutes of Health (NIH), the National Science Foundation and private foundations, according to Sanes.

Research infrastructure work in phase one centered around establishing a design and analysis research core. This core, a nexus of experts and the technology needed for their research, is focused on developing methods and procedures for experimental design and data analysis across the COBRE projects, the Carney Instituteand Brown-affiliated hospitals, Sanes said. It will continue in the next phase.

While continuing to support junior faculty, the phase two grant adds a focus on developing and optimizing neuroimaging analysis tools to better understand the neural basis of behavior through a behavior and neuroimaging core. With techniques like magnetic resonance imaging (MRI) and electroencephalography (EEG), the analysis tools will be a benefit to the broader Brown brain science community, Sanes said.

Phase three, if granted in the years to come, would provide support for the research cores and small, pilot projects.

“To have a successful phase three application in 2023, in addition to the project leaders publishing good papers, getting external funding and giving presentations, we need to demonstrate that the research cores are relevant and useful for the University,” Sanes said.

Eight projects were supported during phase one, with a general focus on normal and abnormal attention and decision-making. They included, among others:

Dima Amso, an associate professor of cognitive, linguistic and psychological sciences, studied context-dependent attention and learning in infant development. She found that both 6-month-old and 10-month-old healthy babies learned where to expect friendly faces from context — a pattern of repeated shapes.

Dr. Wael Asaad, an associate professor of neurosurgery and neuroscience at the Warren Alpert Medical School, focused on the dorsolateral prefrontal cortex and how it integrates sensory information. He found this specific brain region played a key role in assigning cause and effect, which is critical for learning.

Dr. Eric Morrow, an associate professor of molecular biology, cell biology and biochemistry and psychiatry and human behavior, studied a rare autism-like disorder called Christianson syndrome using a combination of genetics, neuroimaging and behavioral observations. He complied the first diagnostic criteria for Christianson syndrome, including a signature genetic mutation and common behavioral and clinical symptoms.

Joo-Hyun Song, an associate professor of cognitive, linguistic and psychological sciences, studied how multiple neural systems in the brain work together to weed out distraction when someone is reaching for objects of different colors. She found that objects that were slightly different, pink compared to red, were more distracting than objects that were blatantly different, such as blue objects.

Michael Worden, an assistant professor of neuroscience (research), studied visual processing in humans by examining cases in which the brain must adapt to conflicting visual stimuli such as arrows pointing in opposite directions that seem to call for incompatible responses.

Karla Kaun, an assistant professor of neuroscience, began her project in the third year of phase one. She studied the molecular basis of cravings and addiction and found in fruit flies that alcohol hijacks a conserved memory pathway in the brain and changes which versions of genes are made.

Phase two projects include:

Theresa Desrochers, an assistant professor of neuroscience and psychiatry and human behavior, will continue work she started in phase one on the role of the frontal cortex in monitoring complex sequences, such as making a cup of coffee.

Amitai Shenhav, an assistant professor of cognitive, linguistic and psychological sciences, is investigating the neural foundation of normal and abnormal decision-making presented with many options, using EEG and MRI. Shenhav’s work is also a continuation of phase one support.

Oriel FeldmanHall, an assistant professor of cognitive, linguistic and psychological sciences, will examine the neural mechanisms of social decision-making. She studies individuals both with and without anxiety disorders make decisions about trusting other people.

Ani Eloyan, an assistant professor of biostatistics, will focus on how brain networks form, change and convey information. She is developing a computational method to estimate the functional connectivity of different areas of the brain using data from MRI signals.

Stephanie Jones, an associate professor of neuroscience, will study how humans perceive sensation, specifically the strength and number of brief events in the beta frequency (as measured by EEG) that are needed to produce a detectible sensation.

Source:

https://news.brown.edu/articles/2018/12/cobre

Tagged with:

About author

Related Articles